| | | | | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | €9,1547 | +0,00% | €221,62M | €28,35K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | €9,1246 | +0,00% | €221,51M | €122,98 | |
ERC Allspring Multi-Sector Income Fund | €7,8045 | +0,06% | €221,47M | €32,66K | |
GLO Clough Global Opportunities Fund | €5,2159 | +0,50% | €221,40M | €43,17K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | €9,1719 | +0,24% | €221,29M | €106,64 | |
TRGS TRG Latin America Acquisitions Corp. Class A Ordinary Shares | €8,4959 | -0,01% | €220,82M | €14,03K | |
CPZ Calamos Long/Short Equity & Dynamic Income Trust Common Stock | €11,0424 | -0,08% | €220,33M | €29,35K | |
| €3,4142 | +2,32% | €220,07M | €76,08K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,4921 | +3,89% | €219,87M | €279,96K | |
PNNT Pennant Investment Corp | €3,4529 | +3,21% | €219,56M | €292,21K | |
VNME Vendome Acquisition Corporation I Class A Ordinary Shares | €8,7763 | -0,05% | €219,29M | €94,60 | |
NUW Nuveen AMT-Free Municipal Value Fund | €12,0486 | +0,36% | €219,22M | €29,21K | |
| €33,9442 | +3,54% | €219,21M | €2,51K | |
DSP Viant Technology Inc. Class A Common Stock | €10,6124 | +1,98% | €219,02M | €55,29K | |
| €25,0088 | +1,82% | €218,91M | €22,29K | |
